IODINE (124I) GIRENTUXIMAB Uses, Dosage, Side Effects and more
IODINE (124I) GIRENTUXIMAB is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).
| Trade Name | IODINE (124I) GIRENTUXIMAB |
| Generic | Girentuximab I-124 |
| Girentuximab I-124 Other Names | IODINE (124I) GIRENTUXIMAB |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
